Received Mar 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | — |
Dialysis after first dose of Shingrix; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of dialysis in a 68-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. On 31-OCT-2024, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced dialysis (Verbatim: Dialysis after first dose of Shingrix). The outcome of the dialysis was unknown. It was unknown if the reporter considered the dialysis to be related to Shingrix. It was unknown if the company considered the dialysis to be related to Shingrix. Additional Information: GSK Receipt Date: 17-MAR-2025 Pharmacist called to report about a patient who received the Shingrix and before getting the second dose, The pharmacist stated, He was not a dialysis patient and he is undergoing dialysis patient with three times a week . The pharmacist enquired if there was any contraindication for getting the vaccine. Patient was undergoing dialysis and Health Care Professional was looking if it was safe to complete the schedule of Shingrix.